Literature DB >> 8248499

Muscarinic acetylcholine receptor subtypes: localization and structure/function.

M R Brann1, J Ellis, H Jørgensen, D Hill-Eubanks, S V Jones.   

Abstract

Based on the sequence of the five cloned muscarinic receptor subtypes (m1-m5), subtype selective antibody and cDNA probes have been prepared. Use of these probes has demonstrated that each of the five subtypes has a markedly distinct distribution within the brain and among peripheral tissues. The distributions of these subtypes and their potential physiological roles are discussed. By use of molecular genetic manipulation of cloned muscarinic receptor cDNAs, the regions of muscarinic receptors that specify G-protein coupling and ligand binding have been defined in several recent studies. Overall, these studies have shown that amino acids within the third cytoplasmic loop of the receptors define their selectivities for different G-proteins and that multiple discontinuous epitopes contribute to their selectivities for different ligands. The residues that contribute to ligand binding and G-protein coupling are described, as well as the implied structures of these functional domains.

Mesh:

Substances:

Year:  1993        PMID: 8248499     DOI: 10.1016/s0079-6123(08)62388-2

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  16 in total

Review 1.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

2.  Human meningiomas possess muscarinic acetylcholine receptors: stimulation of phosphatidylinositol turnover by carbachol.

Authors:  E F Adams; A Hüttner; T Lei; B Rafferty; U Schrell; R Fahlbusch
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

Review 3.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 4.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

5.  Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.

Authors:  M Waelbroeck; S Lazareno; O Pfaff; T Friebe; M Tastenoy; E Mutschler; G Lambrecht
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

6.  Thermal imaging of receptor-activated heat production in single cells.

Authors:  O Zohar; M Ikeda; H Shinagawa; H Inoue; H Nakamura; D Elbaum; D L Alkon; T Yoshioka
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

7.  Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.

Authors:  Helena-F Wrzos; Tarun Tandon; Ann Ouyang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Central muscarinic receptor subtypes involved in pilocarpine-induced salivation, hypertension and water intake.

Authors:  T L Borella; L A De Luca; D S A Colombari; J V Menani
Journal:  Br J Pharmacol       Date:  2008-09-29       Impact factor: 8.739

9.  Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia.

Authors:  Jean-Pierre Raufman; Roxana Samimi; Nirish Shah; Sandeep Khurana; Jasleen Shant; Cinthia Drachenberg; Guofeng Xie; Jürgen Wess; Kunrong Cheng
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

10.  Brain muscarinic receptor subtypes mediating water intake and Fos following cerebroventricular administration of bethanecol in rats.

Authors:  Neil E Rowland; Laura J Farnbauch; Kimberly L Robertson
Journal:  Psychopharmacology (Berl)       Date:  2003-03-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.